These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10745096)

  • 1. NB-506, an indolocarbazole topoisomerase I inhibitor, binds preferentially to triplex DNA.
    Ren J; Bailly C; Chaires JB
    FEBS Lett; 2000 Mar; 470(3):355-9. PubMed ID: 10745096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities.
    Bailly C; Qu X; Chaires JB; Colson P; Houssier C; Ohkubo M; Nishimura S; Yoshinari T
    J Med Chem; 1999 Jul; 42(15):2927-35. PubMed ID: 10425102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence and structural selectivity of nucleic acid binding ligands.
    Ren J; Chaires JB
    Biochemistry; 1999 Dec; 38(49):16067-75. PubMed ID: 10587429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A DNA binding indolocarbazole disaccharide derivative remains highly cytotoxic without inhibiting topoisomerase I.
    Qu X; Chaires JB; Ohkubo M; Yoshinari T; Nishimura S; Bailly C
    Anticancer Drug Des; 1999 Oct; 14(5):433-42. PubMed ID: 10766298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tight binding of the antitumor drug ditercalinium to quadruplex DNA.
    Carrasco C; Rosu F; Gabelica V; Houssier C; De Pauw E; Garbay-Jaureguiberry C; Roques B; Wilson WD; Chaires JB; Waring MJ; Bailly C
    Chembiochem; 2002 Dec; 3(12):1235-41. PubMed ID: 12465032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intercalation into DNA is not required for inhibition of topoisomerase I by indolocarbazole antitumor agents.
    Bailly C; Dassonneville L; Colson P; Houssier C; Fukasawa K; Nishimura S; Yoshinari T
    Cancer Res; 1999 Jun; 59(12):2853-60. PubMed ID: 10383146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA cleavage by topoisomerase I in the presence of indolocarbazole derivatives of rebeccamycin.
    Bailly C; Riou JF; Colson P; Houssier C; Rodrigues-Pereira E; Prudhomme M
    Biochemistry; 1997 Apr; 36(13):3917-29. PubMed ID: 9092822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition of specific sequences in DNA by a topoisomerase I inhibitor derived from the antitumor drug rebeccamycin.
    Bailly C; Colson P; Houssier C; Rodrigues-Pereira E; Prudhomme M; Waring MJ
    Mol Pharmacol; 1998 Jan; 53(1):77-87. PubMed ID: 9443934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced binding to DNA and topoisomerase I inhibition by an analog of the antitumor antibiotic rebeccamycin containing an amino sugar residue.
    Bailly C; Qu X; Anizon F; Prudhomme M; Riou JF; Chaires JB
    Mol Pharmacol; 1999 Feb; 55(2):377-85. PubMed ID: 9927631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple helix-forming oligonucleotides conjugated to indolocarbazole poisons direct topoisomerase I-mediated DNA cleavage to a specific site.
    Arimondo PB; Bailly C; Boutorine AS; Moreau P; Prudhomme M; Sun JS; Garestier T; Hélène C
    Bioconjug Chem; 2001; 12(4):501-9. PubMed ID: 11459453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indolocarbazole glycosides in inactive conformations.
    Facompré M; Carrasco C; Vezin H; Chisholm JD; Yoburn JC; Van Vranken DL; Bailly C
    Chembiochem; 2003 May; 4(5):386-95. PubMed ID: 12740810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence polarization studies of the binding of BMS 181176 to DNA.
    Krishnan BS; Moore ME; Lavoie CP; Long BH; Dalterio RA; Wong HS; Rosenberg IE
    J Biomol Struct Dyn; 1994 Dec; 12(3):625-36. PubMed ID: 7727062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the recognition surface of a DNA triplex: binding studies with intercalator-neomycin conjugates.
    Xue L; Xi H; Kumar S; Gray D; Davis E; Hamilton P; Skriba M; Arya DP
    Biochemistry; 2010 Jul; 49(26):5540-52. PubMed ID: 20499878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of camptothecin-resistant mammalian cell lines to evaluate the role of topoisomerase I in the antiproliferative activity of the indolocarbazole, NB-506, and its topoisomerase I binding site.
    Urasaki Y; Laco G; Takebayashi Y; Bailly C; Kohlhagen G; Pommier Y
    Cancer Res; 2001 Jan; 61(2):504-8. PubMed ID: 11212241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berenil [1,3-bis(4'-amidinophenyl)triazene] binding to DNA duplexes and to a RNA duplex: evidence for both intercalative and minor groove binding properties.
    Pilch DS; Kirolos MA; Liu X; Plum GE; Breslauer KJ
    Biochemistry; 1995 Aug; 34(31):9962-76. PubMed ID: 7632695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of topoisomerase I-mediated DNA cleavage by a new indolocarbazole, ED-110.
    Yoshinari T; Yamada A; Uemura D; Nomura K; Arakawa H; Kojiri K; Yoshida E; Suda H; Okura A
    Cancer Res; 1993 Feb; 53(3):490-4. PubMed ID: 8381047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The binding of analogues of coralyne and related heterocyclics to DNA triplexes.
    Latimer LJ; Payton N; Forsyth G; Lee JS
    Biochem Cell Biol; 1995; 73(1-2):11-8. PubMed ID: 7662309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Energetics of strand-displacement reactions in triple helices: a spectroscopic study.
    Mills M; Arimondo PB; Lacroix L; Garestier T; Hélène C; Klump H; Mergny JL
    J Mol Biol; 1999 Sep; 291(5):1035-54. PubMed ID: 10518941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermodynamics of nucleic acid "shape readout" by an aminosugar.
    Xi H; Davis E; Ranjan N; Xue L; Hyde-Volpe D; Arya DP
    Biochemistry; 2011 Oct; 50(42):9088-113. PubMed ID: 21863895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel antitumor indolocarbazole compound 6-N-formylamino-12,13-dihydro-1,11- dihydroxy-13-(beta-D-glucopyranosyl)-5H-indolo[2,3-a]pyrrolo[3,4- c]carbazole-5,7(6H)-dione (NB-506): induction of topoisomerase I-mediated DNA cleavage and mechanisms of cell line-selective cytotoxicity.
    Yoshinari T; Matsumoto M; Arakawa H; Okada H; Noguchi K; Suda H; Okura A; Nishimura S
    Cancer Res; 1995 Mar; 55(6):1310-5. PubMed ID: 7882328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.